Wordt geladen...
Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials
BACKGROUND: The phosphatidylinositol-3- kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway (PI3K/AKT/mTOR pathway) plays a key role in cancer. We performed this meta-analysis to assess the clinical effect of using PI3K/AKT/mTOR pathway inhibitors on advanced solid tumours. METHODS: All t...
Bewaard in:
Gepubliceerd in: | PLoS One |
---|---|
Hoofdauteurs: | , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Public Library of Science
2018
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5800666/ https://ncbi.nlm.nih.gov/pubmed/29408858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0192464 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|